Ads
related to: boston scientific
Search results
What Drove A Nearly 2x Rise In Boston Scientific’s Profits?
Forbes· 6 days agoBoston Scientific (NYSE: BSX) saw its net income expand by $0.9 billion or 145% y-o-y to $1.6 billion in 2023. This can primarily be attributed to an expansion ...
Boston Scientific’s cardiac rhythm system hits pivotal trial goals
MedTech Dive via Yahoo Finance· 7 days agoDive Brief: Boston Scientific’s modular cardiac rhythm management system met pre-specified safety...
Boston Scientific (BSX) Rides on Emerging Markets, MedSurg
Zacks· 5 days agoFree Report) is gaining traction in the emerging markets. New regulatory approvals bode well for the company’s growth. Boston Scientific continues to expand ...
ResMed (RMD) Up 16.3% Since Last Earnings: Will it Continue?
Zacks via Yahoo Finance· 3 hours agoKey Picks Some other stocks in the broader medical space that have announced quarterly results are...
Reasons to Hold Cencora (COR) Stock in Your Portfolio for Now
Zacks via Yahoo Finance· 7 hours agoPrice Cencora, Inc. price | Cencora, Inc. Quote Key Picks Some better-ranked stocks in the broader...
Inari Medical (NARI) Sues Truvic on Patent Infringement
Zacks via Yahoo Finance· 4 hours agoInari Medical (NARI) files a patent infringement lawsuit against Imperative Care and its subsidiary...
If You Invested $100 In This Stock 10 Years Ago, You Would Have $600 Today - Boston Scientific...
Benzinga· 5 days agoBoston Scientific BSX has outperformed the market over the past 10 years by 8.59% on an annualized basis producing an average annual return of 19.33%. Currently ...
Medtronic touts demand for PFA, adding to hype for the new ablation tech
MedTech Dive via Yahoo Finance· 4 days agoCEO Geoff Martha told investors there has already been “strong adoption” of PFA devices and the...
ResMed (RMD) Up 16.3% Since Last Earnings: Will it Continue?
Zacks· 14 hours agoResMed, Inc.‘s (RMD Quick QuoteRMD - Free Report) shares have increased 16.3% since last earnings compared with the industry’s rise of 1.3%. The company has a market capitalization of $31.33 ...
Reasons to Hold Cencora (COR) Stock in Your Portfolio for Now
Zacks· 14 hours agoFree Report) is well-poised for growth on the back of robust U.S. Healthcare Solutions business and product launches. Shares of this Zacks Rank #3 (Hold) company have risen 6.6% year to date ...